Rodriguez F, Slifka M K, Harkins S, Whitton J L
Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037, USA.
J Virol. 2001 Aug;75(16):7399-409. doi: 10.1128/JVI.75.16.7399-7409.2001.
Subdominant CD8(+) T-cell responses contribute to control of several viral infections and to vaccine-induced immunity. Here, using the lymphocytic choriomeningitis virus model, we demonstrate that subdominant epitopes can be more reliably identified by DNA immunization than by other methods, permitting the identification, in the virus nucleoprotein, of two overlapping subdominant epitopes: one presented by L(d) and the other presented by K(d). This subdominant sequence confers immunity as effective as that induced by the dominant epitope, against which >90% of the antiviral CD8(+) T cells are normally directed. We compare the kinetics of the dominant and subdominant responses after vaccination with those following subsequent viral infection. The dominant CD8(+) response expands more rapidly than the subdominant responses, but after virus infection is cleared, mice which had been immunized with the "dominant" vaccine have a pool of memory T cells focused almost entirely upon the dominant epitope. In contrast, after virus infection, mice which had been immunized with the "subdominant" vaccine retain both dominant and subdominant memory cells. During the acute phase of the immune response, the acquisition of cytokine responsiveness by subdominant CD8(+) T cells precedes their development of lytic activity. Furthermore, in both dominant and subdominant populations, lytic activity declines more rapidly than cytokine responsiveness. Thus, the lysis(low)-cytokine(competent) phenotype associated with most memory CD8(+) T cells appears to develop soon after antigen clearance. Finally, lytic activity differs among CD8(+) T-cell populations with different epitope specificities, suggesting that vaccines can be designed to selectively induce CD8(+) T cells with distinct functional attributes.
亚优势CD8(+) T细胞应答有助于控制多种病毒感染并促进疫苗诱导的免疫。在此,我们使用淋巴细胞性脉络丛脑膜炎病毒模型证明,与其他方法相比,通过DNA免疫能够更可靠地鉴定亚优势表位,从而在病毒核蛋白中鉴定出两个重叠的亚优势表位:一个由L(d)呈递,另一个由K(d)呈递。这种亚优势序列赋予的免疫力与优势表位诱导的免疫力一样有效,通常>90%的抗病毒CD8(+) T细胞针对该优势表位。我们比较了接种疫苗后与随后病毒感染后的优势和亚优势应答动力学。优势CD8(+)应答比亚优势应答扩展得更快,但在病毒感染清除后,用“优势”疫苗免疫的小鼠的记忆T细胞库几乎完全集中在优势表位上。相比之下,病毒感染后,用“亚优势”疫苗免疫的小鼠同时保留了优势和亚优势记忆细胞。在免疫应答的急性期,亚优势CD8(+) T细胞获得细胞因子反应性先于其裂解活性的发展。此外,在优势和亚优势群体中,裂解活性的下降比亚优势应答扩展得更快。因此,与大多数记忆CD8(+) T细胞相关的低裂解活性-细胞因子活性(正常)表型似乎在抗原清除后不久就出现了。最后,具有不同表位特异性的CD8(+) T细胞群体的裂解活性有所不同,这表明可以设计疫苗来选择性诱导具有不同功能特性的CD8(+) T细胞。